Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 87,658 shares at $2.84 ($214K) on 2023-04-11, disclosed to the SEC on 2023-04-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.28 | 31,329 | $71K | 33.4% |
| 2 | $2.28 | 31,329 | $71K | 33.4% |
| 3 | $2.84 | 25,000 | $71K | 33.2% |
| Total | $2.44 avg | 87,658 | $214K | 100% |
| Filing → |
| AVTX | BUY | 2023-06-14 | $64K | — | Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |